MedPath
HSA Approval

KENHANCER PLASTER 30 mg/sheet

SIN10769P

KENHANCER PLASTER 30 mg/sheet

KENHANCER PLASTER 30 mg/sheet

February 25, 1999

EMERGING PHARMA (S) PTE LTD

EMERGING PHARMA (S) PTE LTD

Regulatory Information

EMERGING PHARMA (S) PTE LTD

EMERGING PHARMA (S) PTE LTD

Therapeutic

General Sale List

Formulation Information

PLASTER

【 **Dosage & Administration**】 Apply 1 sheet of Kenhancer to the affected area twice a day.

TOPICAL

Medical Information

【 **Indication**】 Kenhancer is used to relieve pain and swelling in a number of painful conditions affecting the joints, muscle and tendon. Kenhancer relieves rheumatic and muscular pain, and reduces swelling and inflammation such as arthritis, painful shoulder syndrome, inflammation of tendon and sheath that surrounds the tendon. Kenhancer is also indicated for tennis elbow, sore muscle and pain resulting from trauma.

Under 【 **Precautions & side effects**】 1\. Do not apply to the patients of the followings 1. Patients with history of hypersensitivity to this drug. 2. Patients with aspirin induced asthma (nonsteroidal anti-inflammatory drug induced asthma) or with history of it.

M02AA10

ketoprofen

Manufacturer Information

EMERGING PHARMA (S) PTE LTD

GC BIOPHARMA CORP.

Active Ingredients

KETOPROFEN

30 mg/sheet

Ketoprofen

Documents

Patient Information Leaflets

Kenhancer Plaster IL and_PIL.pdf

Approved: February 16, 2023

Download
© Copyright 2025. All Rights Reserved by MedPath